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Restless legs syndrome (RLS) is a neurological disorder characterized by leg paresthesia associated with an irresistible
urge to move that often interferes with nocturnal sleep, leading to chronic sleep deprivation. To map genes that
may play a role in the vulnerability to RLS, a genomewide scan was conducted in a large French-Canadian family.
Significant linkage was established on chromosome 12q, for a series of adjacent microsatellite markers with a
maximum two-point LOD score of 3.42 (recombination fraction .05; ; autosomal recessive mode of54Pp 6 # 10
inheritance), whereas multipoint linkage calculations yielded a LOD score of 3.59. Haplotype analysis refined the
genetic interval, positioning the RLS-predisposing gene in a 14.71-cM region between D12S1044 and D12S78.
These findings represent the first mapping of a locus conferring susceptibility to RLS.
Introduction
Restless legs syndrome (RLS) is a neurological condition
characterized by paresthesia of the lower limbs associ-
ated with an imperative urge to move (Montplaisir et
al. 2000). These symptoms occur particularly during
rest, with at least a partial and temporary relief bymove-
ment. There is a significant worsening of the symptoms
in the evening or during the night, which leads to noc-
turnal sleep disruption, resulting in daytime somnolence.
It is postulated that this periodic oscillation in symptom
intensity may reflect a substantial involvement of the
circadian system (Hening et al. 1999; Trenkwalder et al.
1999).
Although the exact prevalence is uncertain, RLS may
afflict, with varying degrees of severity, 15% of the gen-
eral population (Ekbom 1945; Lavigne and Montplaisir
1994; Phillips et al. 2000). Numerous studies have sug-
gested a substantial genetic contribution in the etiology
of the primary form of RLS. Familial aggregation has
been repeatedly reported since its original clinical de-
scription (Ekbom 1944), with 140% of the idiopathic
cases showing a positive family history (Walters et al.
1996; Montplaisir et al. 1997; Winkelmann et al. 2000).
A recent twin study reported that ∼83% of twin pairs
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were concordant for RLS (Ondo et al. 2000), suggesting
that a significant portion of the familial aggregation may
be due to genetic factors, which have been thought to be
transmitted in an autosomal dominant mode of inheri-
tance (Trenkwalder et al. 1996; Lazzarini et al. 1999;
Winkelmann et al. 2001). Thus far, fewmolecular-genetic
studies have been undertaken attempting to identify genes
that may predispose to this condition (Johnson et al.
1992; Dichgans et al. 1996; Zai et al. 2000; Desautels
et al. 2001), and no significant finding has been reported.
In this study, we report on the mapping of an RLS
locus on the short arm of chromosome 12, in a well-
documented French-Canadian family, using linkage anal-
ysis ofmicrosatellitemarkers spanning the entire genome.
Subjects, Material, and Methods
Subjects
One large French-Canadian family was investigated,
from which 25 individuals were sampled for linkage (fig.
2). Of these individuals, 14 were considered to be af-
fected and 4 (II:2, II:5, II:6, and II:10) were designated
as having uncertain status. The family was ascertained
through the Center for Sleep Disorders in Montre´al, and
diagnoses were made by one experienced clinician skilled
in the assessment of sleep disorders (J.M.), according to
the criteria of the International Restless Legs Syndrome
Study Group (Walters 1995): leg paresthesia, associated
with an urge to move; motor restlessness; worsening of
symptoms during rest, with partial relief by movement;
and worsening of symptoms during the evening and
night.
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Table 1





p q f1 f2 f0
Dominant 1 .99 .01 .9 0 0
Dominant 2 .95 .05 .5 0 .005
Recessive .75 .25 .005 .005 .8
NOTE.—v between males and females was considered to be equal.
All subjects were interviewed personally, at two dif-
ferent times during a 10-year follow-up interval. Follow-
up is particularly useful in evaluation of RLS, consid-
ering that disease severity may fluctuate over the
patient’s lifetime (Walters et al. 1996). All clinical eval-
uations were performed blind to the genotype status.
Polysomnographic recordings were performed to doc-
ument periodic leg movements in sleep in some affected
subjects (III:4 and III:5) and in the proband (II:4).
None of the subjects were affected with any condition
known to cause nonidiopathic RLS or with any other
neurologic or sleep disorder, including sleep apnea syn-
drome, rapid-eye-movement sleep behavior disorders, and
narcolepsy. In addition, none of the subjects reported the
use of medication known to affect sleep, sensory, ormotor
functions. The study protocol was approved by the local
institutional review board, and written informed consent
was obtained from all participants.
Genotyping
Genomic DNA was isolated from peripheral lympho-
cytes or from transformed lymphoblastoid cell lines, fol-
lowing standard methods (Sambrook et al. 1989). Ge-
notyping was conducted at the Genome Centre at
Montreal General Hospital, by use of a modified Multi-
Probe-I (Packard) and two ABI 377 DNA sequencers. The
panel of microsatellite markers was obtained from the
Whitehead Institute as a modified version of the Coop-
erative Human Linkage Center human screening set (Du-
bovsky et al. 1995) and consisted of 378 polymorphic,
fluorescently labeled markers, covering the entire genome,
with an average intermarker spacing of 10 cM. The
marker map positions were based on the sex-averaged
maps from the Marshfield Medical Research Foundation.
Gels were analyzed in an automated system, and, after a
visual inspection, generated fileswere automatically trans-
ferred to a UNIX system. Lane tracking, allele binning,
and inheritance checking were performed using NEW-
MAT, the Bass/Grace gel-analysis system, and PEDMAN-
AGER softwares. Allele frequencies were derived from a
random sample of French Canadian subjects. Further-
more, two polymorphisms were manually genotyped to
increase the marker density in the region of chromosome
12q.
Linkage Analysis
Two-point LOD score was calculated using the
MLINK routine of the FASTLINK software package,
version 5.1 (Lathrop et al. 1984; Cottingham et al. 1993;
Scha¨ffer 1996). Keeping the pedigree structure, simu-
lations were performed to assess empirical P values by
use of SIMULATE (Ott 1989). The replicates were
subsequently analyzed with the MSIM program of the
SLINK software (Ott 1989; Weeks et al. 1990). Since
the mode of inheritance of RLS is unknown, pairwise
LOD scores were maximized over three major models
(table 1). In the region showing significant evidence of
linkage, location-score analysis and haplotyping were
computed by the SIMWALK2 program (Sobel and Lange
1996).
Results
Parametric two-point linkage analysis revealed a max-
imum LOD score ( ) 11.0 at 12 loci on three differentZmax
chromosomes (fig. 1). All significant and suggestive re-
sults were observed under the autosomal recessive mode
of inheritance, with a high disease-predisposing allele
frequency. The strongest evidence of linkage was de-
tected with eight adjacent microsatellite markers geno-
typed between D12S398 and D12S78 on chromosome
12q13-23. In this 44-cM region, the LOD scores were
within the range from 1.71 to 3.42, with a maximum
LOD score for D12S1044 ( at recombina-Z p 3.42max
tion fraction [v] .05; ). Furthermore, sug-4Pp 6# 10
gestive evidence of linkage was established with marker
GGAT1A4 on locus 10q22 ( at ;Z p 2.17 vp 0max
) and a region spanning 19 cM on chro-3Pp 2# 10
mosome 5q31, which showed a maximum LOD score
of 1.51 with marker D5S816 ( ; ).3vp .2 Pp 5# 10
Given the strength of the linkage result on chromosome
12, we opted to further analyze this locus. Multipoint
analysis was performed on chromosome 12 under the
recessive model. These calculations provided additional
support for the localization of RLS-predisposing loci to
chromosome 12q, yielding a maximum multipoint LOD
score of 3.59 at a position 13.93 cM centromeric from
marker D12S1300.
Haplotype construction and analysis of recombina-
tion events between the RLS phenotype and the markers
that span the region of interest were used to define the
smallest cosegregating region (SCR) in this family (fig.
2). In this pedigree, the disease-causing gene is telomeric
to D12S1044 and centromeric to D12S78, defining a
14.71-cM interval within chromosome 12q. Consistent
with the autosomal recessive model of inheritance with
a high carrier frequency, which reflects a high disease-
allele frequency in the population, several haplotypes
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Figure 1 Maximum two-point LOD scores, plotted against ge-
netic distance along chromosomes containing regions that provided
two-point LOD scores 11.0. “AD” denotes that an autosomal dom-
inant model was used; “AR” denotes that an autosomal recessive
model was used.
cosegregate with the affected phenotype. Themost com-
mon haplotypes shared by affected subjects are 3-2-5
and 4-3-2 for markers D12S1044 through D12S78, in-
herited from founder I:2, as well as haplotype 3-3-2,
inherited from individual I:1.
Discussion
This finding represents the first identification of a major
genetic locus for the RLS phenotype. By use of a ge-
nomewide approach, the mapping of a large French-
Canadian kindred provided significant evidence for a
susceptibility locus on chromosome 12q, supported by
a multipoint LOD score of 3.59. Haplotype analysis re-
vealed that, in this family, the disease gene is likely to
be located within a 14.71-cM region between markers
D12S1044 and D12S78.
Although parametric linkage analysis does not allow
the determination of the true underlying mode of in-
heritance of RLS, the genetic parameters that provide
the highest LOD score may approximate the real genetic
model, given that there is linkage and the result is not
spurious (Hodge and Elston 1994). If this is correct, our
results suggest a pseudodominant pattern, in which the
true mode of inheritance is autosomal recessive but,
because of a high disease-carrier frequency, there are
frequent homozygote-heterozygote matings and conse-
quent disease diversity.
We cannot exclude the possibility that other genes
may influence the occurrence of the phenotype. This
seems particularly likely for RLS, considering the high
prevalence rate and the substantial variability in the
severity of symptoms observed in the general popula-
tion. It would not be unexpected that several genetic
loci, along with greater or smaller contributions from
environmental factors, determine the ultimate pheno-
type of each gene carrier.
Several plausible candidate genes have been mapped
within the region of interest (i.e., between markers
D12S1044 and D12S78). Among these are the putative
orthologue of the timeless gene (TIM) in Drosophila
(Koike et al. 1998) and the gene encoding the trideca-
peptide neurotensin (NTS) (Marondel et al. 1996).
Among other things, NTS is reported to act as a neu-
romodulator of the dopaminergic (DA) transmission
(Ervin et al. 1981; Kalivas et al. 1983), and autoradi-
ographic analyses have shown a dense localization of
NTS receptors on DA-containing neurons (Quirion et
al. 1985; Szigethy and Beaudet 1989). This is particu-
larly relevant, since several lines of evidence implicate
the DA system in the pathogenesis of RLS (Montplaisir
et al. 1999; Turjanski et al. 1999).
We are continuing our efforts toward the identifica-
tion of RLS genes, through recruitment and analysis of
new affected families, to confirm this result and to refine
the genetic interval to a size more suitable for positional
cloning. The identification of a susceptibility gene for
RLS potentially will lead to a better clinical character-
ization, as well as to the development of diagnostic tests
and new modalities for treatment.
Desautels et al.: Susceptibility Locus for RLS 1269
Figure 2 Pedigree drawing of the family analyzed, showing haplotypes for six markers located on chromosome 12q. The marker order,
from centromere to telomere, is given to the left of each generation. Inferred haplotypes are bracketed. Individuals whose DNA sample was
genotyped are indicated by asterisks (*), and unblackened symbols containing a cross () denote subjects of unknown disease status (e.g., II:2
and II:6). Double daggers (‡) indicate subjects who are probably affected (II:5 and II:10) but who were not clinically assessed (they were
considered as having unknown phenotypes for the linkage analyses). A question mark (?) denotes unknown alleles. The haplotype segregating
with the RLS phenotype is boxed.
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